Wolverine Trading
OPRX icon

Wolverine Trading’s OptimizeRx OPRX Stock Holding History

Wolverine Trading’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$406K Buy
19,800
+5,900
+42% +$93.6K ﹤0.01% 3948
2025
Q2 		$190K Buy
+13,900
New +$152K ﹤0.01% 3942
2023
Q1 		– Sell
-45,800
Closed -$769K – 4745
2022
Q4 		$769K Buy
+45,800
New +$792K ﹤0.01% 2030
2021
Q4 		– Sell
-11,000
Closed -$825K – 6554
2021
Q3 		$825K Sell
11,000
-8,800
-44% -$552K ﹤0.01% 3254
2021
Q2 		$1.22M Buy
19,800
+4,800
+32% +$244K ﹤0.01% 2553
2021
Q1 		$696K Buy
+15,000
New +$724K ﹤0.01% 3239

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wolverine Trading's OPRX Position: Q4 2021 in Review

Wolverine Trading sold out of OptimizeRx (OPRX) in Q4 2021, closing a stake of 10,040 shares — an estimated $753K sold.

Wolverine Trading first reported a position in OPRX in Q1 2021 and held it in 2 quarters. The position peaked at $753K in Q3 2021. 180 funds tracked by Wall St. Rank hold OPRX as of Q4 2021.

  • Wolverine Trading reported no remaining OptimizeRx position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 10,040 OptimizeRx shares in Q4 2021, an estimated $753K.
  • Wolverine Trading first reported a position in OptimizeRx in Q1 2021 and held it in 2 quarters.
  • Wolverine Trading's OptimizeRx position peaked at $753K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.